Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-10-11

FDA Approved: OTREXUP — Original Application (Antares Pharma, Inc.)

View source ↗

Summary

FDA approved OTREXUP, a subcutaneous methotrexate injection from Antares Pharma, under an original NDA for autoimmune conditions including rheumatoid arthritis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTREXUP (Methotrexate)

Snippet

ORIG AP for OTREXUP (METHOTREXATE)